Oral Minoxidil 2.5 mg - Side Effects

1. Hypertrichosis (Most Common)

• Increased, thickened, and darker body hair - most often on the face (temples, between eyebrows, upper lip, sideburns), then spreading to arms, legs, back
• Appears within 3-6 weeks of starting treatment
• More common in women than men, and in those with genetically darker body hair
• At 2.5 mg, the risk is lower than at 5 mg (where up to 93% of men are affected)
• Fully reversible 1-6 months after stopping - but does not reverse on its own while taking the drug
• Can be managed with shaving or depilatory creams; in women, concurrent spironolactone may reduce it

2. Fluid Retention / Edema

• Presents as ankle/lower leg swelling (pedal edema), facial swelling, periorbital puffiness, or rapid weight gain
• Occurs due to vasodilation causing compensatory sodium and water retention
• Reported incidence is low at low doses (~1.3% in studies)
• Management: reduce dietary sodium (<2 g/day), add a diuretic (furosemide or spironolactone in women); discontinuation reverses it

3. Cardiovascular Effects

• Tachycardia / palpitations - reflex tachycardia from vasodilation; reported in ~0.9% at low doses
• Postural/orthostatic hypotension - lightheadedness on standing; reported in ~1.7%
• Headache - from vasodilation; reported in ~0.4%
• A 2025 systematic review and meta-analysis (PMID: 39521141) specifically confirmed that low-dose oral minoxidil does not significantly affect blood pressure at hair loss doses
• Rare but serious: pericardial effusion and pericarditis have been reported (mostly at higher antihypertensive doses)
• At 2.5 mg, serious cardiovascular effects are uncommon but patients with pre-existing heart disease need more careful monitoring

4. Neurological / Other

• Insomnia (~0.2%)
• Fatigue or malaise - during the initial adjustment period
• Nausea - rarely reported

5. Contraindications / Special Cautions

• Pregnancy/breastfeeding: contraindicated - fetal hypertrichosis and congenital anomalies have been reported
• Pheochromocytoma: contraindicated (can worsen hypertension via reflex catecholamine release)
• Pre-existing cardiac or renal disease: use with caution; monitor closely

Practical Management Tips

• Dermatology 2-Volume Set 5e (Dermatology textbook), p. 3160
• Goodman & Gilman's Pharmacological Basis of Therapeutics
• Chen M et al. "Low-dose oral minoxidil does not significantly affect blood pressure: A systematic review and meta-analysis." J Am Acad Dermatol 2025 Mar [PMID: 39521141]

Clinical note: At 2.5 mg, the side effect profile is generally well-tolerated. The most likely issue patients will experience is some degree of hypertrichosis, particularly women. Serious cardiovascular events are rare at this dose but baseline cardiovascular screening is still recommended before starting.